Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neurophysiology of Fibromyalgia

NCT: NCT06006130 · COMPLETED

NCT IDNCT06006130
StatusCOMPLETED
Start Date2024-02-01
Completion2025-12-31
SponsorMcMaster University (OTHER)
First posted
Last updated

Brief Summary

Fibromyalgia is a syndrome associated with fatigue and chronic pain, leading to significant physical limitations and impaired quality of life. There are several challenges that complicate the diagnosis and management of fibromyalgia. The etiology is not well defined, as there are several proposed factors that may trigger the genesis of pain in fibromyalgia including physical and/or emotional life stressors, and genetic predispositions involving neuromodulator pathways. Chronic pain in fibromyalgia arises in the absence of tissue pathology, and consequently a lack of consensus on reliable diagnostic criteria. Understanding the neurophysiology of fibromyalgia would aid in the discovery of objective biomarkers for diagnosis. Therefore, the goals of this study are to: 1. Compare the neurophysiological responses in fibromyalgia compared to healthy controls. 2. Determine whether a two-week cTMS protocol will alter pain in individuals with fibromyalgia.

Frequently Asked Questions

What is Neurophysiology of Fibromyalgia?

Neurophysiology of Fibromyalgia is a clinical trial registered under NCT06006130. Current status: COMPLETED.

What is the status of NCT06006130?

The current status of NCT06006130 (Neurophysiology of Fibromyalgia) is: COMPLETED.

When did Neurophysiology of Fibromyalgia start?

Neurophysiology of Fibromyalgia started on 2024-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.